Arkolith/Insider Trading/AVIR/Form 4

Foster Wayne

EVP, Chief Accounting OfficerAtea Pharmaceuticals, Inc. (AVIR) · full profile →Form 4 · filed Feb 4, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 31, 2025Option exercise(M)33K——54K
Jan 31, 2025Grant(A)8K——62K
Jan 31, 2025Tax withholding(F)12K$3.06$37K50K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 31, 2025Option exercise(M)33K—$033K
Jan 31, 2025Grant(A)8K—$08K
Jan 31, 2025Grant(A)120K—$0120K

Transaction Codes

M
Option exercise / conversion
A
Grant / award
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-013844) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML